Skip to main content
Top
Published in: Journal of Cancer Survivorship 3/2015

01-09-2015

Follow-up patterns of cancer survivors: a survey of Canadian radiation oncologists

Authors: Allison Y. Ye, Winson Y. Cheung, Karen J. Goddard, Daniel Horvat, Robert A. Olson

Published in: Journal of Cancer Survivorship | Issue 3/2015

Login to get access

Abstract

Purpose

With continual advancements in cancer care, improved outcomes, and increasing survivors, survivorship has become an important area of research. This project seeks to determine the current status of follow-up care in oncology.

Methods

An electronic survey was sent to the Canadian Association of Radiation Oncology members. Based on brief clinical scenarios pertaining to various survivor populations, questions were posed to determine routine follow-up practices.

Results

One hundred eleven radiation oncologists (RO) responded (44 % response rate); 29 % were female, 43 % were in practice <10 years, and most of Canada was represented. Most worked in centers with >10 oncologists (69 %) and saw >200 new consults per year (78 %). Only 10 % reported not following their patients routinely, mainly in those with breast cancer. Most would follow their central nervous system, gastrointestinal, head and neck, gynecologic, and genitourinary patients. Lack of resources and a belief that follow-up by family physicians (FPs) is equally effective were the top reasons for not following. Treatment toxicity and possibility of further treatment were the most common reasons for routine follow-up. The majority (55 %) would follow patients for <5 years, with 36 % for 5–10 years, and a minority (9 %) for longer than 10 years; 54 % would not change the frequency of follow-up, but 39 % would decrease and only 7 % would increase follow-up. Some felt transferring more care to other health professionals would require additional training and more guidelines. Survivorship care plans are underutilized.

Conclusions

Transfer of follow-up care to FPs is desired and feasible. This would allow for more comprehensive medical care and improve access to care for newly diagnosed patients. The development and usage of survivorship care plans would improve this care.

Implications for cancer survivors

Survivors may be increasingly followed by family physicians. Better coordination between oncologists and family physicians, including the use of survivorship care plans, may facilitate this transition.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in transition. Washington: The National Academies Press; 2006. Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in transition. Washington: The National Academies Press; 2006.
3.
go back to reference Tjandra JJ, Chan MK. Follow-up after curative resection of colorectal cancer: a meta-analysis. Dis Colon Rectum. 2007;50:1783–99.CrossRefPubMed Tjandra JJ, Chan MK. Follow-up after curative resection of colorectal cancer: a meta-analysis. Dis Colon Rectum. 2007;50:1783–99.CrossRefPubMed
4.
go back to reference Jeffery M, Hickey BE, Hider PN. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev. 2007;1, CD002200.PubMed Jeffery M, Hickey BE, Hider PN. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev. 2007;1, CD002200.PubMed
5.
go back to reference Renehan AG, Egger M, Saunders MP, O'Dwyer ST. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ. 2002;324:813.PubMedCentralCrossRefPubMed Renehan AG, Egger M, Saunders MP, O'Dwyer ST. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ. 2002;324:813.PubMedCentralCrossRefPubMed
6.
go back to reference Rosen M, Chan L, Beart Jr RW, Vukasin P, Anthone G. Follow-up of colorectal cancer: a meta-analysis. Dis Colon Rectum. 1998;41:1116–26.CrossRefPubMed Rosen M, Chan L, Beart Jr RW, Vukasin P, Anthone G. Follow-up of colorectal cancer: a meta-analysis. Dis Colon Rectum. 1998;41:1116–26.CrossRefPubMed
7.
go back to reference Figueredo A, Rumble RB, Maroun J, et al. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer. 2003;3:26.PubMedCentralCrossRefPubMed Figueredo A, Rumble RB, Maroun J, et al. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer. 2003;3:26.PubMedCentralCrossRefPubMed
8.
go back to reference Papagrigoriadis S. Follow-up of patients with colorectal cancer: the evidence is in favour but we are still in need of a protocol. Int J Surg. 2007;5:120–8.CrossRefPubMed Papagrigoriadis S. Follow-up of patients with colorectal cancer: the evidence is in favour but we are still in need of a protocol. Int J Surg. 2007;5:120–8.CrossRefPubMed
9.
go back to reference Augestad KM, Rose J, Crawshaw B, Cooper G, Delaney C. Do the benefits outweigh the side effects of colorectal cancer surveillance? A systematic review. World J Gastrointest Oncol. 2014;6:104–11.PubMedCentralCrossRefPubMed Augestad KM, Rose J, Crawshaw B, Cooper G, Delaney C. Do the benefits outweigh the side effects of colorectal cancer surveillance? A systematic review. World J Gastrointest Oncol. 2014;6:104–11.PubMedCentralCrossRefPubMed
10.
go back to reference Kew FM, Roberts AP, Cruickshank DJ. The role of routine follow-up after gynecological malignancy. Int J Gynecol Cancer. 2005;15:413–9.CrossRefPubMed Kew FM, Roberts AP, Cruickshank DJ. The role of routine follow-up after gynecological malignancy. Int J Gynecol Cancer. 2005;15:413–9.CrossRefPubMed
11.
go back to reference Kew FM, Cruickshank DJ. Routine follow-up after treatment for a gynecological cancer: a survey of practice. Int J Gynecol Cancer. 2006;16:380–4.CrossRefPubMed Kew FM, Cruickshank DJ. Routine follow-up after treatment for a gynecological cancer: a survey of practice. Int J Gynecol Cancer. 2006;16:380–4.CrossRefPubMed
12.
go back to reference Vistad I, Moy BW, Salvesen HB, Liavaag AH. Follow-up routines in gynecological cancer—time for a change? Acta Obstet Gynecol Scand. 2011;90:707–18.CrossRefPubMed Vistad I, Moy BW, Salvesen HB, Liavaag AH. Follow-up routines in gynecological cancer—time for a change? Acta Obstet Gynecol Scand. 2011;90:707–18.CrossRefPubMed
13.
go back to reference Dalbagni G, Bochner BH, Cronin A, Herr HW, Donat SM. A plea for a uniform surveillance schedule after radical cystectomy. J Urol. 2011;185:2091–6.CrossRefPubMed Dalbagni G, Bochner BH, Cronin A, Herr HW, Donat SM. A plea for a uniform surveillance schedule after radical cystectomy. J Urol. 2011;185:2091–6.CrossRefPubMed
14.
go back to reference Richert-Boe KE. Heterogeneity of cancer surveillance practices among medical oncologists in Washington and Oregon. Cancer. 1995;75:2605–12.CrossRefPubMed Richert-Boe KE. Heterogeneity of cancer surveillance practices among medical oncologists in Washington and Oregon. Cancer. 1995;75:2605–12.CrossRefPubMed
15.
go back to reference Schwartz DL, Barker Jr J, Chansky K, et al. Postradiotherapy surveillance practice for head and neck squamous cell carcinoma—too much for too little? Head Neck. 2003;25:990–9.CrossRefPubMed Schwartz DL, Barker Jr J, Chansky K, et al. Postradiotherapy surveillance practice for head and neck squamous cell carcinoma—too much for too little? Head Neck. 2003;25:990–9.CrossRefPubMed
17.
go back to reference Virgo KS, Chan D, Handler BS, Johnson DY, Goshima K, Johnson FE. Current practice of patient follow-up after potentially curative resection of cutaneous melanoma. Plast Reconstr Surg. 2000;106:590–7.CrossRefPubMed Virgo KS, Chan D, Handler BS, Johnson DY, Goshima K, Johnson FE. Current practice of patient follow-up after potentially curative resection of cutaneous melanoma. Plast Reconstr Surg. 2000;106:590–7.CrossRefPubMed
18.
go back to reference Parmeshwar R, Margenthaler JA, Allam E, Chen L, Virgo KS, Johnson FE. Patient surveillance after initial breast cancer therapy: variation by physician specialty. Am J Surg. 2013;206:218–22.CrossRefPubMed Parmeshwar R, Margenthaler JA, Allam E, Chen L, Virgo KS, Johnson FE. Patient surveillance after initial breast cancer therapy: variation by physician specialty. Am J Surg. 2013;206:218–22.CrossRefPubMed
22.
go back to reference Del Giudice ME, Grunfeld E, Harvey BJ, Piliotis E, Verma S. Primary care physicians’ views of routine follow-up care of cancer survivors. J Clin Oncol. 2009;27:3338–45.CrossRefPubMed Del Giudice ME, Grunfeld E, Harvey BJ, Piliotis E, Verma S. Primary care physicians’ views of routine follow-up care of cancer survivors. J Clin Oncol. 2009;27:3338–45.CrossRefPubMed
24.
25.
go back to reference Mayer DK, Gerstel A, Walton AL, et al. Implementing survivorship care plans for colon cancer survivors. Oncol Nurs Forum. 2014;41:266–73.CrossRefPubMed Mayer DK, Gerstel A, Walton AL, et al. Implementing survivorship care plans for colon cancer survivors. Oncol Nurs Forum. 2014;41:266–73.CrossRefPubMed
26.
27.
go back to reference Salz T, Oeffinger KC, McCabe MS, Layne TM, Bach PB. Survivorship care plans in research and practice. CA Cancer J Clin 2012;62(2):101–17. Salz T, Oeffinger KC, McCabe MS, Layne TM, Bach PB. Survivorship care plans in research and practice. CA Cancer J Clin 2012;62(2):101–17.
29.
go back to reference Shayne M, Culakova E, Milano MT, Dhakal S, Constine LS. The integration of cancer survivorship training in the curriculum of hematology/oncology fellows and radiation oncology residents. J Cancer Surviv. 2014;8:167–72.CrossRefPubMed Shayne M, Culakova E, Milano MT, Dhakal S, Constine LS. The integration of cancer survivorship training in the curriculum of hematology/oncology fellows and radiation oncology residents. J Cancer Surviv. 2014;8:167–72.CrossRefPubMed
Metadata
Title
Follow-up patterns of cancer survivors: a survey of Canadian radiation oncologists
Authors
Allison Y. Ye
Winson Y. Cheung
Karen J. Goddard
Daniel Horvat
Robert A. Olson
Publication date
01-09-2015
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 3/2015
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-014-0390-2

Other articles of this Issue 3/2015

Journal of Cancer Survivorship 3/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine